His Job Is to Sell a $1,000 Pill for $10 Without Losing Money

  • `We make a good target,' says Gilead Sciences' access chief
  • Debate about rationing access to a life-saving medicine

Gregg Alton has what seems like a disorienting job at Gilead Sciences Inc. He’s paid to figure out how to sell the drug Sovaldi, which infamously retails in the U.S. at $1,000 a pill, for relatively next to nothing.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.